WuXi Biologics Tech Stack
Global biologics CDMO with 430k+ liters planned manufacturing capacity across five continents
WuXi Biologics operates a multinational contract development and manufacturing organization (CDMO) for biopharmaceuticals, spanning discovery through commercial-scale production. The hiring profile is heavily weighted toward manufacturing (91 roles) and engineering (41 roles), with active recruitment across the U.S., China, Singapore, Ireland, and Germany — reflecting aggressive capacity buildout. Current project backlog centers on process validation, technology transfer, and new facility commissioning, while internal pain points cluster around GMP compliance, regulatory navigation, and automation optimization.
Tech Stack 99 technologies
What WuXi Biologics Is Building
◆Challenges
- Ensuring gmp compliance
- Meeting regulatory requirements
- Reducing costs
- Continuous improvement of automation processes
- Reducing project risk
- Compliance with gmp regulations
- Ensuring timely calibration
- Workflow impediments
- Optimizing resource utilization
- Audit readiness
▲Active Projects
- Process validation
- New product introduction
- Cmc strategy development
- Npi improvement projects
- Technology transfer projects
- New facility design and validation for ais systems
- Technical transfer
- Equipment startup and validation
- Policy training program implementation
- Installation and qualification of new manufacturing equipment
Hiring Activity
Department
Seniority
Notable leadership hires: Audit Director, CMC Lead, Director CMC, Medical Director, Business Development Director
